San Diego's world-class health care sector is developing life-changing therapies poised to help millions. Yesterday in @EnergyCommerce, I advocated for a system that does not stifle this research now or in the future.pic.twitter.com/ABnZRFDXuW
-
-
Show this thread
-
Diagnostics for rare diseases can take years of expensive testing and too much guess work. Our bill, the Ending the Diagnostic Odyssey Act, would expand access to whole genome sequencing —which is already being deployed in San Diego— and reduce costs for families in the long run.
Show this thread -
Low-income patients face unique health & socioeconomic challenges. We must ensure patients already disadvantaged by limited treatment options can continue to access specialized drugs for substance abuse & mental health disorders under Medicare Part D.
:https://bit.ly/2Jiw7IX Show this thread -
Markets with competition work to drive down costs. If the government interferes with pricing before the market has had the chance to work, it could prevent the next breakthrough from coming to market at all.
:https://bit.ly/2BrnzuE Show this thread -
We want and need a market that continues to produce new drugs and therapies that can cure deadly and chronic disease. I made clear my concerns with parts of this bill and look forward to working with my colleagues to further improve it.
Show this thread
End of conversation
New conversation -
-
-
Yes, indeed. Thanks,
@RepScottPeters. This is what economists call a positive externality. Given low appropriability in the market, the government can step in to encourage more innovation and investment.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.